Goodarzi Amir, Thaci Bart, Toussi Atrin, Karnati Tejas, Kim Kee, Fragoso Ruben
Department of Neurological Surgery, University of California, Davis, School of Medicine, Sacramento, California, USA.
Department of Neurological Surgery, University of California, Davis, School of Medicine, Sacramento, California, USA.
World Neurosurg. 2019 Apr;124:101-109. doi: 10.1016/j.wneu.2018.12.164. Epub 2019 Jan 10.
Primary spinal glioblastoma multiforme (GBM) of the conus medullaris is a rare and devastating pathologic entity. The presenting symptoms commonly include progressive neurologic deficits in the lower extremities, bowel and bladder dysfunction, and low back pain. Histologically, these tumors have high-grade features similar to their intracranial counterparts. However, recent advancements in the field of molecular oncology have been beginning to elucidate a unique molecular blueprint for these spinal gliomas. Given the lack of standardized treatment strategies, we have presented our institutional experience in treating a small series of patients with conus medullaris GBM and have reviewed the reported data on the relevant molecular markers, management strategies, and complication avoidance for this malignant pathologic entity.
圆锥马尾原发性多形性胶质母细胞瘤(GBM)是一种罕见且具有毁灭性的病理实体。其呈现的症状通常包括下肢进行性神经功能缺损、肠道和膀胱功能障碍以及腰痛。从组织学上看,这些肿瘤具有与颅内同类肿瘤相似的高级别特征。然而,分子肿瘤学领域的最新进展已开始阐明这些脊髓胶质瘤独特的分子蓝图。鉴于缺乏标准化的治疗策略,我们介绍了我们机构治疗一小系列圆锥马尾GBM患者的经验,并回顾了有关该恶性病理实体的相关分子标志物、管理策略和并发症预防的报道数据。